The U.S. Securities and Exchange Commission (SEC) is signaling support for streamlined “minimum effective dose” disclosure rules and tightly scoped equity‑tokenization pilots via an innovation exemption, according to new remarks from Chair Paul S. Atkins. The U.S. Securities and Exchange…
Related Posts
Crypto expers hail Clarity Act and GENIUS Act as turning point for the industry
The passage of three landmark crypto bills will have longstanding effects on the industry.
Syndicate Labs suffers $380k SYND bridge exploit, pledges full user compensation
Syndicate Labs has confirmed that a leaked upgrade key let an attacker hijack its Commons cross-chain bridge, drain…
Hong Kong plans to flag suspicious crypto platforms amid JPEX scandal
The Securities and Futures Commission (SFC) of Hong Kong is intensifying the fight against unregulated cryptocurrency platforms in…